46. Microincisional cataract surgery and Thinoptx rollable intraocular lens implantation
45. Effects of caffeine on intraocular pressure: the Blue Mountains Eye Study
44. Therapeutic strategies for normal-tension glaucoma
43. Primary lensectomy following acute primary angle closure glaucoma
42. Otago Glaucoma Surgery Outcome Study: follow-up of young patients who underwent Molteno implant surgery
41. Recent progress in ocular drug delivery for posterior segment disease: Emphasis on transscleral iontophoresis
40. Effect of additive preoperative latanoprost treatment on the outcome of filtration surgery
39. Long-term clinical results of selective laser trabeculoplasty in the treatment of primary open angle glaucoma
38. Short- and medium-term intraocular pressure lowering effects of combined phacoemulsification and non-penetrating deep sclerectomy without scleral
37. Bimatoprost: a pharmacoeconomic review of its use in open-angle glaucoma and ocular hypertension
36. Trabeculectomy for the management of uveitic glaucoma
35. Observational survey on the use of dual therapy in ocular hypertension or glaucoma treatment
34. Glaucoma in children: are we making progress?
33. Baerveldt glaucoma implant in paediatric patients
32. 24-hour intraocular pressure control obtained with evening- versus morning-dosed travoprost in primary open-angle glaucoma
31. The effect of aspirin and warfarin therapy in trabeculectomy
30. Long-term results of Molteno implant insertion in cases of neovascular glaucoma
29. Ahmed Glaucoma Valve implantation in African American and white patients
28. Treating ocular hypertension to reduce glaucoma risk : when to treat?
27. Rescula as an alternative therapy for Beta-blockers with long-term drift effect in glaucoma patients
26. Effects of bimatoprost 0.03% on ocular hemodynamics in normal tension glaucoma
25. Long-term outcome of pediatric aphakic glaucoma
24. Prospective, long-term evaluation of steroid-induced glaucoma
23. Effects of Topical Hypotensive Drugs on Circadian IOP, Blood Pressure, and Calculated Diastolic Ocular Perfusion Pressure in Patients with Glaucoma
22. IOP-Lowering Efficacy of Bimatoprost 0.03% and Travoprost 0.004% in Patients with Glaucoma or Ocular Hypertension
21. Ocular hypotensive efficacy and safety of brinzolamide ophthalmic suspension 1% added to travoprost ophthalmic solution 0.004% therapy in patients
20. Long-term results of surgery in childhood glaucoma
19. Long-term follow-up of selective laser trabeculoplasty in primary open-angle glaucoma
18. Efficacy of laser trabeculoplasty in phakic and pseudophakic patients with primary open-angle glaucoma.
17. Dose, timing and frequency of subconjunctival 5-fluorouracil injections after glaucoma filtering surgery
16. Neovascular glaucoma : Aetiology, pathogenesis and treatment
15. The additive effect of topical dorzolamide and systemic acetazolamide in pediatric glaucoma
14. Intraocular Pressure-Lowering Effect of Adding Dorzolamide or Latanoprost to Timolol A Meta-analysis of Randomized Clinical Trials
13. A comparative analysis of the effects of the fixed combination of timolol and dorzolamide versus latanoprost plus timolol on ocular hemodynamics and
12. Glaucoma
11. The clinical applications of Fluorouracil in ophthalmic practice
10. Cortisone glaucoma: epidemiological, clinical, and therapeutic study
09. A double-masked, randomized, parallel comparison of a fixed combination of bimatoprost 0.03%/timolol 0.5% with non-fixed combination use in patients w
08. Experience with the polymer-coated hydroxyapatite implant after enucleation in 126 patients
07. Endoscopic laser cyclophotocoagulation in pediatric glaucoma with corneal opacities
06. Endoscopic diode laser cyclophotocoagulation in the management of aphakic and pseudophakic glaucoma in children
05. Glaucoma surgery and retinal pathology
04. Nonpenetrating glaucoma surgery: a critical evaluation
03. What is Glaucoma?
02. Are You at Risk For Glaucoma?
01. A Glaucoma Gene
